Loading
Latest filing published 19 Nov 2021 for Cortexyme, Inc., €24k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Casey Lynch discloses dealings in IRulya Therapeutics Inc. to SEC (Form 4). Between 10 May 2021 and 18 November 2021, the trades on record add up to 2 filings.
Every open-market trade on record is a sale: 1 sale worth €378k. Other entries cover 1 option exercise.
The record was last updated on 19 November 2021 with an option exercise (€24k) in IRulya Therapeutics Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations